Sermorelin Peptide Side Effects and Risks
Sermorelin peptide therapy is generally well tolerated, especially when prescribed at physiological (not supraphysiological) levels. However, as with any hormone-affecting treatment, side effects can occur—ranging from mild and temporary to more serious in rare cases.
Common and Mild Side Effects
The most frequently reported side effects are mild and short-lived. These may include:
Injection site reactions such as redness, swelling, or itching
Headaches
Flushing or warmth in the face
Mild dizziness or fatigue during the first few weeks
These effects often resolve as the body adjusts to increased GH activity. In a study of adults using GHRH analogs, injection site irritation occurred in roughly 10% of patients.³
Rare and Serious Adverse Reactions
More significant side effects are rare but possible. These include:
Nausea or vomiting
Sleep disturbances
Carpal tunnel–like symptoms (e.g., tingling in hands or wrists)
Gynecomastia (breast tissue swelling in men), though far less likely than with synthetic HGH
People with underlying pituitary tumors, untreated thyroid issues, or hormone-sensitive cancers should be screened before starting therapy.
Sermorelin Long-Term Side Effects
Long-term data on sermorelin peptide use is limited, but its mechanism—stimulating natural GH release instead of replacing it—may reduce the risk of hormonal suppression or dependence that’s sometimes seen with synthetic HGH.
Still, regular lab monitoring (especially IGF-1 and fasting glucose levels) is essential to track efficacy and safety over time.